Gamma Medica and Mayo Clinic Publish Preliminary Results of Low Dose Molecular Breast Imaging Screening Study for Women with Dense Breasts
NORTHRIDGE, Calif.--(BUSINESS WIRE)--Published in the April issue of Journal of Nuclear Medicine, Gamma Medica, Inc. and Mayo Clinic of Rochester, MN release the much anticipated preliminary results of a Low Dose Molecular Breast Imaging (MBI) Screening Study in Women with Dense Breasts.